Skip to main content
Log in

High-dose intravenous gamma-globulin therapy for myasthenia gravis

  • Letters To The Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Devathasan G, Kueh YK, Chong PN (1984) High-dose intravenous gammaglobulin for myasthenia gravis. Lancet II:809–810

    Google Scholar 

  2. Fateh-Moghadam A, Wick M, Besinger V, Gemsen RG (1984) High-dose intravenous gammaglobulin for myasthenia gravis. Lancet I:848–849

    Google Scholar 

  3. Gajdos P, Outin H, Elkharrat D, Brunel D, Rohan-Chabot P, Raphael JC, Goulon M, Goulon-Goeau C, Morel E (1984) High-dose intravenous gammaglobulin for myasthenia gravis. Lancet I:406–407

    Google Scholar 

  4. Ippoliti G, Cosi V, Piccolo G, Lombardi M, Mantegaz R (1984) High-dose intravenous gammaglobulin for myasthenia gravis. Lancet II:809

    Google Scholar 

  5. Mossman S, Vincent A, Newsom-Davis J (1986) Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity. Lancet I:116–118

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ibars, I.B., Ponseti, J., Español, T. et al. High-dose intravenous gamma-globulin therapy for myasthenia gravis. J Neurol 234, 363 (1987). https://doi.org/10.1007/BF00314298

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00314298

Keywords

Navigation